Beta-2-Adrenoceptor Agonist For The Treatment Of Cough

Patent No. EP2906218 (titled "Beta-2-Adrenoceptor Agonist For The Treatment Of Cough") was filed by Boehringer Ingelheim on Oct 7, 2013. The application was issued on Dec 14, 2016.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSSep 13, 2017TEVA PHARMACEUTICALS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2906218

BOEHRINGER INGELHEIM
Application Number
EP13773749A
Filing Date
Oct 7, 2013
Status
Revoked
Apr 27, 2018
Publication Date
Dec 14, 2016